David McDermott, MD
Urology · Annapolis, MDNPI 1730184177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $837 and has fallen 65.4% since, to $290 in 2025. That places this record below the midpoint for urology clinicians in MD, where the typical reported total is $4,190.
Across 95 payments — averaging $27.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$390
- Bayer$333
- Sumitomo Pharma America, Inc.$209
- Olympus America Inc.$164
- Dendreon Pharmaceuticals LLC$163
- Pfizer$139
- plus $1K from 22 others
Across 1 payment — averaging $16,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$16K
What the payments were for
- Food & beverage$2,617100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $390 |
| Bayer | 15 | $333 |
| Sumitomo Pharma America, Inc. | 9 | $209 |
| Olympus America Inc. | 3 | $164 |
| Dendreon Pharmaceuticals LLC | 3 | $163 |
| Pfizer | 4 | $139 |
| Telix Pharmaceuticals | 2 | $136 |
| AstraZeneca | 1 | $125 |
| Endo Pharmaceuticals Inc. | 7 | $118 |
| AbbVie | 2 | $100 |
| Baxter Healthcare | 1 | $95 |
| Neotract Inc. | 1 | $94 |
| Myovant Sciences Inc. | 3 | $84 |
| Urogen Pharma, Inc. | 3 | $71 |
| Astellas Pharma US Inc | 3 | $68 |
| Merck | 3 | $55 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Renovia Inc | 1 | $31 |
| Tolmar, Inc. | 1 | $28 |
| Valencia Technologies Corporation | 1 | $26 |
| Steris Corporation | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Intuitive Surgical | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$235
- iTIND System$127
- IMFINZI$125
- PROVENGE$109
How this compares
$2,617 in reported general payments places this provider in the 40th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 105 | $2,213 |
| Finasteride | 93 | $1,824 |
Paid to pharmacies, not to this prescriber.
Other urology in Annapolis
- Richard LevinAnnapolis$51K
- Juddson ChasonAnnapolis$20K
- Shaoqing ZhouAnnapolis$15K
- James MastersonAnnapolis$14K
- Mara HoltonAnnapolis$13K
- Christopher GrazianoAnnapolis$12K
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.